India's Dr Reddy's says FDA raises fresh concerns at Srikakulam drug plant

MUMBAI (Reuters) - India's Dr Reddy's Laboratories Ltd said on Tuesday that the U.S. Food and Drug Administration has outlined two more concerns with the company's Srikakulam drug-making plant after an inspection of the facility.